Bibliography
- DINARELLO CA: Role of pro- and anti-inflammatory cy-tokines during inflammation: experimental and clini-cal findings. J. Biol. Regul. HomeosL Agents (1997) 11(3):91–103.
- LOWE C: Tumour necrosis factor-a antagonists andtheir therapeutic applications. Exp. Opin. Ther. Patents (1998) 8(10):1309–1322.
- CAMUSSI G, LUPIA E: The future role of anti-tumour ne-crosis factor (TNF) products in the treatment of rheu-matoid arthritis. Drugs (1998) 55(5):613–620.
- MORELAND LW: Soluble tumor necrosis factor receptor(p75) fusion protein (ENBREL) as a therapy for rheu-matoid arthritis. Rheum. Dis. Clin. North Am. (1998) 24 (3):579–591.
- DINARELLO CA: Interleukin-1, interleukin-1 receptorsand interleukin-1 receptor antagonist. InL Rev. Immu-nol. (1998) 16(5-6):457–499.
- CONDLIFFE AM, KITCHEN E, CHILVERS ER: Neutrophilpriming: pathophysiological consequences and un-derlying mechanisms. Clin. Sci. (1998) 94(5):461–471.
- GOUGEROT-PODICALO MA, ELBIM C, CHOLLET-MARTINS: Modulation of the oxidative burst of human neutro-phils by pro- and anti-inflammatory cytokines. Pathol. Biol. (1996) 44(0:36–41.
- BRATTSAND R, LINDEN M: Cytokine modulation by glu-cocorticoids: mechanisms and actions in cellular stud-ies. Aliment. Pharmacol. Ther. (1996) 10(S2):81–92.
- JOYCE DA, STEER JH, ABRAHAM LJ: Glucocorticoid modulation of human monocyte/macrophage func-tion: control of TNF-alpha secretion. Inflamm. Res. (1997) 46(10:447–451.
- DAVIDSEN SK, SUMMERS JB: Inhibitors of TNFa synthe-sis. Exp. Opin. Ther. Patents (1995) 5(10):1087–1100.
- CHIOU GCY, LIU SXL: Novel, non-traditional, non-steroidal, anti-inflammatory agents. Exp. Opin. Ther. Patents (1996) 6(0:41–56.
- LAHTI RA, GALL M: Conversion of N-alkylaminobenzophenones to benzodiazepines in vivo. J. Med. Chem. (1976) 19(8):1064–1067.
- LAZZARINI R, PAULINO CA, MALUCELLI BE, PALERMO-NETO J: Effects of high doses of diazepam on carrageenin-induced paw edema in rats. Braz. J. Med. Biol. Res. (1996) 29(10:1525–1529.